default logo

Archive for July, 2017

Asthma Therapeutics in Asia-Pacific Markets Forecast to Grow from $4.1 billion in 2016 to $6 billion by 2023, at a compound annual growth rate (CAGR) of 5.4%

Asthma is a common chronic inflammatory disease of the airways of the lungs. It is characterized by frequent attacks of breathlessness and wheezing that vary in frequency and severity from patient to patient. Variable gradations of airflow obstruction, bronchial hyper-responsiveness a

Read More